Pyramidal Cell Hypofunction Predicts Psychosis Conversion in High Risk Patients

The clinical high risk syndrome represents a critical developmental window where early intervention may fundamentally alter the trajectory of schizophrenia spectrum disorders [1, 2]. While approximately 20 percent to 30 percent of these individuals transition to full psychosis within two years, current clinical assessments often struggle to provide precise individual prognoses [3]. Electrophysiological markers, specifically those measuring how the brain processes unexpected auditory stimuli, have emerged as low cost tools with significant potential for risk stratification [4]. However, the utility of these biomarkers in routine practice remains limited because their underlying cellular mechanisms have long been unclear [3, 5]. A new study now utilizes biophysical modeling (a computational method that uses mathematical equations to simulate the electrical activity of specific neuron types) to clarify the specific synaptic failures that precede the first psychotic episode.